“…EN2 is a transcription factor involved in early embryo development of PCa and thus is only expressed in PCa cells and secreted into urine. 5 , 45 , 46 , 47 , 48 , 49 , 50 , 51 , 52 The detection of urinary EN2 is currently based on ELISA, but the sensitivity and specificity are only 66%–80% and 80%–88%, respectively. 5 , 45 , 46 , 47 This study has demonstrated that the 3p3 immunoassay shows superior sensitivity and specificity in the urinary EN2 detection of PCa patients—no false‐negative signals for PCa patients (100% sensitivity) and no false‐positive signals for other prostate‐related diseases (BPH and BCa) and healthy controls (100% specificity)—indicating that this innovative approach is highly suitable as a novel immunoassay platform for simple urine test‐based, clinical in vitro cancer diagnosis.…”